173 related articles for article (PubMed ID: 9188553)
41. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
42. A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.
Shiroki K; Ishii T; Aoki T; Kobashi M; Ohka S; Nomoto A
J Virol; 1995 Nov; 69(11):6825-32. PubMed ID: 7474095
[TBL] [Abstract][Full Text] [Related]
43. Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis.
Brown DM; Kauder SE; Cornell CT; Jang GM; Racaniello VR; Semler BL
J Virol; 2004 Feb; 78(3):1344-51. PubMed ID: 14722289
[TBL] [Abstract][Full Text] [Related]
44. One hundred years of poliovirus pathogenesis.
Racaniello VR
Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
[TBL] [Abstract][Full Text] [Related]
45. Down regulation of poliovirus receptor RNA in HeLa cells resistant to poliovirus infection.
Kaplan G; Racaniello VR
J Virol; 1991 Apr; 65(4):1829-35. PubMed ID: 1705991
[TBL] [Abstract][Full Text] [Related]
46. Age-dependent poliovirus replication in the mouse central nervous system is determined by internal ribosome entry site-mediated translation.
Kauder S; Kan S; Racaniello VR
J Virol; 2006 Mar; 80(6):2589-95. PubMed ID: 16501069
[TBL] [Abstract][Full Text] [Related]
47. Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.
Freistadt MS; Eberle KE
Microb Pathog; 2000 Oct; 29(4):203-12. PubMed ID: 10993739
[TBL] [Abstract][Full Text] [Related]
48. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
49. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.
Strauss M; Filman DJ; Belnap DM; Cheng N; Noel RT; Hogle JM
J Virol; 2015 Apr; 89(8):4143-57. PubMed ID: 25631086
[TBL] [Abstract][Full Text] [Related]
50. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.
Cello J; Paul AV; Wimmer E
Science; 2002 Aug; 297(5583):1016-8. PubMed ID: 12114528
[TBL] [Abstract][Full Text] [Related]
51. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
[TBL] [Abstract][Full Text] [Related]
52. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.
Lancaster KZ; Pfeiffer JK
PLoS Pathog; 2010 Mar; 6(3):e1000791. PubMed ID: 20221252
[TBL] [Abstract][Full Text] [Related]
53. Intestinal microbiota promote enteric virus replication and systemic pathogenesis.
Kuss SK; Best GT; Etheredge CA; Pruijssers AJ; Frierson JM; Hooper LV; Dermody TS; Pfeiffer JK
Science; 2011 Oct; 334(6053):249-52. PubMed ID: 21998395
[TBL] [Abstract][Full Text] [Related]
54. Early events in poliovirus infection: virus-receptor interactions.
Racaniello VR
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11378-81. PubMed ID: 8876143
[TBL] [Abstract][Full Text] [Related]
55. Identification of 50- and 23-/25-kDa HeLa cell membrane glycoproteins involved in poliovirus infection: occurrence of poliovirus specific binding sites on susceptible and nonsusceptible cells.
Barnert RH; Zeichhardt H; Habermehl KO
Virology; 1992 Feb; 186(2):533-42. PubMed ID: 1310182
[TBL] [Abstract][Full Text] [Related]
56. Tissue tropism and species specificity of poliovirus infection.
Nomoto A; Koike S; Aoki J
Trends Microbiol; 1994 Feb; 2(2):47-51. PubMed ID: 8162441
[TBL] [Abstract][Full Text] [Related]
57. Expression of poliovirus receptor in human spinal cord and muscle.
Leon-Monzon ME; Illa I; Dalakas MC
Ann N Y Acad Sci; 1995 May; 753():48-57. PubMed ID: 7611659
[TBL] [Abstract][Full Text] [Related]
58. Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge.
Taffs RE; Chernokhvostova YV; Dragunsky EM; Nomura T; Hioki K; Beuvery EC; Fitzgerald EA; Levenbook IS; Asher DM
J Infect Dis; 1997 Feb; 175(2):441-4. PubMed ID: 9203668
[TBL] [Abstract][Full Text] [Related]
59. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus.
Aoki J; Koike S; Ise I; Sato-Yoshida Y; Nomoto A
J Biol Chem; 1994 Mar; 269(11):8431-8. PubMed ID: 8132569
[TBL] [Abstract][Full Text] [Related]
60. Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway.
Selinka HC; Zibert A; Wimmer E
Proc Natl Acad Sci U S A; 1991 May; 88(9):3598-602. PubMed ID: 1673787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
